Literature DB >> 19372745

Trading mtDNA uncovers its role in metastasis.

Kaori Ishikawa1, Jun-Ichi Hayashi.   

Abstract

It has been controversial for many years of whether mtDNA mutations are involved in phenotypes related to cancer due to the difficulty in excluding possible involvement of nuclear DNA mutations in these phenotypes. We addressed this issue by complete trading of mtDNAs between tumor cells expressing different metastatic phenotypes. Resultant trans-mitochondrial cybrids share the same nuclear background, but possess mtDNA from tumor cells expressing different metastatic phenotypes, and thus can be used to uncover the role of mtDNA in these phenotypes. The results showed that mtDNA controls development of metastasis in tumor cells, while tumor development is controlled by nuclear genome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372745      PMCID: PMC2675141          DOI: 10.4161/cam.3.1.6838

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  30 in total

1.  Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA.

Authors:  K Nakada; K Inoue; T Ono; K Isobe; A Ogura; Y I Goto; I Nonaka; J I Hayashi
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

2.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

Authors:  B E Baysal; R E Ferrell; J E Willett-Brozick; E C Lawrence; D Myssiorek; A Bosch; A van der Mey; P E Taschner; W S Rubinstein; E N Myers; C W Richard; C J Cornelisse; P Devilee; B Devlin
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

Review 3.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

Review 4.  Mitochondrial tumour suppressors: a genetic and biochemical update.

Authors:  Eyal Gottlieb; Ian P M Tomlinson
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

Review 5.  Mitochondrial DNA mutations in human neoplasia.

Authors:  Anna M Czarnecka; Pawel Golik; Ewa Bartnik
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

6.  Facile detection of mitochondrial DNA mutations in tumors and bodily fluids.

Authors:  M S Fliss; H Usadel; O L Caballero; L Wu; M R Buta; S M Eleff; J Jen; D Sidransky
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

7.  m.6267G>A: a recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors.

Authors:  M Esther Gallardo; Raquel Moreno-Loshuertos; Celia López; Mercedes Casqueiro; Javier Silva; Felix Bonilla; Santiago Rodríguez de Córdoba; José Antonio Enríquez
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

8.  Generation of trans-mitochondrial mice carrying homoplasmic mtDNAs with a missense mutation in a structural gene using ES cells.

Authors:  Atsuko Kasahara; Kaori Ishikawa; Makiko Yamaoka; Masahito Ito; Naoki Watanabe; Miho Akimoto; Akitsugu Sato; Kazuto Nakada; Hitoshi Endo; Yoko Suda; Shinichi Aizawa; Jun-Ichi Hayashi
Journal:  Hum Mol Genet       Date:  2006-01-31       Impact factor: 6.150

Review 9.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

10.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

View more
  3 in total

Review 1.  From discovery of the CHOP axis and targeting ClpP to the identification of additional axes of the UPRmt driven by the estrogen receptor and SIRT3.

Authors:  Timothy C Kenny; Doris Germain
Journal:  J Bioenerg Biomembr       Date:  2017-08-10       Impact factor: 2.945

2.  Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma.

Authors:  C Tang; Y Hou; H Wang; K Wang; H Xiang; X Wan; Y Xia; J Li; W Wei; S Xu; Z Lei; T M Pawlik; H Wang; M Wu; F Shen
Journal:  Oncogenesis       Date:  2017-07-17       Impact factor: 7.485

Review 3.  mtDNA, Metastasis, and the Mitochondrial Unfolded Protein Response (UPRmt).

Authors:  Timothy C Kenny; Doris Germain
Journal:  Front Cell Dev Biol       Date:  2017-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.